Time：
2026-03-30 16:35
Author：
xieyijun
On Perseverance, Transformation, and Expectation
Time：
2026-03-29 17:47
Author：
xieyijun
AI pharmaceuticals welcome the 'Chinese moment'
Standing in the spotlight, waiting
Time：
2026-03-29 09:00
Author：
xieyijun
Multinational Pharmaceutical Companies Increase Investment in China
A Vote of Confidence Worth Over Hundreds of Billions
Time：
2026-03-26 08:38
Author：
xieyijun
Chinese pharmaceutical companies "challenge" the world's most expensive drugs.
Time：
2026-03-25 09:13
Author：
xieyijun
Behind the 80% Rejection Rate: Crossing FDA's "First Threshold"
Why CMC Determines the Success or Failure of New Drug Approval
Time：
2026-03-24 09:23
Author：
xieyijun
A Sea Change Is Coming to China’s GLP-1 Market
Time：
2026-03-20 20:29
Author：
xieyijun
Recommended content
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
After rejecting a $30 billion acquisition offer, a biotech company has emerged as a giant
determination for independence
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务